Dora Dias‐Santagata

21.8k citations
112 papers · 7.8k indexed · 3 hit papers · h-index 44
Topics
Lung Cancer Treatments and Mutations (24 papers)Cancer Genomics and Diagnostics (22 papers)Genetic factors in colorectal cancer (14 papers)
Partner nations
United StatesJapanCanada

In The Last Decade

Dora Dias‐Santagata

106 papers receiving 7.7k citations

Hit Papers

EGFR-Mediated Reactivation of MAPK Signaling Contributes ...2011202620162021201220112013250500750

Peers

Dora Dias‐Santagata
Comparison fields: 5 of 127
  • Oncology 3.5k
  • Molecular Biology 3.2k
  • Pulmonary and Respiratory Medicine 2.2k
  • Cancer Research 1.6k
  • Pathology and Forensic Medicine 1.2k
Replace Shikha Bose with:
Shikha Bose United States
Barry S. Taylor United States
Mathew J. Garnett United Kingdom
Jordi Rodón United States
Yardena Samuels United States
Vladimir Lazar France
Sarat Chandarlapaty United States
Rileen Sinha United States
Aurélien de Reyniès France
Yevgeniy Antipin United States
Dora Dias‐Santagata relative to Shikha Bose United States Shikha Bose's profile →
Citations per field
00.5×
Shikha Bose · 1×
Citations per year

Countries citing papers authored by Dora Dias‐Santagata

Since Specialization
Citations

This map shows the geographic impact of Dora Dias‐Santagata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Dias‐Santagata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Dias‐Santagata more than expected).

Fields of papers citing papers by Dora Dias‐Santagata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dora Dias‐Santagata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Dias‐Santagata. The network helps show where Dora Dias‐Santagata may publish in the future.

Co-authorship network of co-authors of Dora Dias‐Santagata

This figure shows the co-authorship network connecting the top 25 collaborators of Dora Dias‐Santagata. A scholar is included among the top collaborators of Dora Dias‐Santagata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dora Dias‐Santagata. Dora Dias‐Santagata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 18
3 9
4 13
5 12
6 76
7 78
8 27
9 33
10 13
11 16
12 130
13 72
14 52
15 89
16 87
17
EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenibbreakdown →
767
18 37
19 405
20 13

About Dora Dias‐Santagata

Dora Dias‐Santagata is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 112 papers that have together received 7.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (24 papers), Cancer Genomics and Diagnostics (22 papers) and Genetic factors in colorectal cancer (14 papers). The work is most often cited by research in Oncology (3.5k citations), Cancer Research (1.6k citations) and Genetics (781 citations). Dora Dias‐Santagata has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include A. John Iafrate, Jeffrey A. Engelman, Darrell R. Borger, Jeffrey Settleman, Mari Mino–Kenudson, Mel Β. Feany, Peter M. Sadow, Ryan B. Corcoran, Tudor A. Fulga and Leif W. Ellisen. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026